- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Excelra
Excelra is listed as a mid sized business research supplier in the Scientist.com network, with 4 sites in 3 countries.
View Excelra on Scientist.com
Email me this page as a PDF
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Sites
4
Countries
3
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Mid sized business
Agricultural Sciences Compliance and Quality Control Measures
- Exposure Tests which assess human health impact upon exposure of product.
Antibodies
- Antibody Humanization Increase an antibody's similarity to a variant produced naturally in humans.
Biomarkers
- Biomarker Clinical Utility Evaluate the potential clinical applications of a candidate biomarker.
- Biomarker Clinical Validation Evaluate the predictive ability of a candidate biomarker for a disorder.
- Biomarker Discovery Identify a biomarker associated with disease progression of disease, effectiveness of therapy or diagnosis of disease or condition.
- Biomarker Services Evaluating normal/abnormal biological conditions and characteristics within the body
- Diagnostic Biomarkers Discovery Identify candidate biomarkers indicative of the presence of a disorder.
- Metabolomics Biomarker Discovery Identify and quantitate metabolite biomarkers in blood, urine, CSF and bodily fluids.
Show all 13 in Biomarkers
- Multi-Omics Study Use an integrated multi-omics study to understand a disease mechanism.
- Peptide Bioanalysis Analyze the structure of Peptides.
- Pharmacodynamic Biomarkers Discovery Identify candidate biomarkers indicative of the therapeutic outcome of a drug-target interaction.
- Predictive Biomarkers Discovery Identify candidate biomarkers suggestive of a response to a treatment.
- Prognostic Biomarkers Discovery Identify candidate biomarkers representative of disease progression without treatment.
- Single Cell Transcriptome Sequencing Detect distinct, rare or abnomal cell types in a heterogenous population.
- Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
Clinical Consulting
- Biomarker Services Consulting Expert advice to conduct solutions for evaluating normal/abnormal biological conditions and characteristics within the body.
- Biostatistics Consulting Apply statistical theory and mathematical principals to research
Clinical Trials
- Clinical Trial Design Develop study-related protocols, case report forms (CRFs) and database tools for records management.
- Pharmacokinetic Studies Design a study that observes the time course of drug absorption, distribution, metabolism, and excretion, as means to test the safety and effective therapeutic management of drugs in an individual patient.
- Prospective Explorative Studies Conduct a prospective exploratory study to assess the safety and efficacy of a test drug during clinical trials.
- Trial Insights: Clinical Trials Intelligence Dashboard Trial Insights is the industry’s first digital research reporting dashboard made specifically to track ongoing clinical trials, observational, diagnostic and medical device studies. The solution aggregates and curates...
Show all 199 services
Commercial Consulting
- Portfolio Management Manage a portfolio of projects in early-stage drug discovery and provide factors that determine the success of the proposed portfolio.
Data Science/Bioinformatics
- Clinical Biomarker Analysis An approach to finding markers that change in response to a drug or that identify a group that responds favorably to a specific therapy. These can be omics, molecular, histologic, radiologic, etc.
- Clinical Companion Diagnostics Analysis The process of finding patients who are likely to respond positively to a drug and designing a diagnostic tool to identify this group of patients before or with a therapy.
- Clinical Data Science and Modeling A process that helps make sense of your clinical data
- Clinical In Silico Drug Dynamics The process to understand drug dynamics by computer analysis and simulation.
- Clinical In Silico Genomics/Transcriptomics Data Analysis A process that helps make sense of your omics data
- Clinical Machine Learning/AI Complex analytical approaches to find patterns and make predictions in drug discovery projects
Show all 43 in Data Science/Bioinformatics
- Clinical Responder Analysis, Patient Stratification The process of identifying patients that are more likely to respond positively to a drug.
- Discovery Biomarker Analytics An approach to finding markers that change in response to a drug or that identify a group that responds favorably to a specific therapy. These can be omics, molecular, histologic, radiologic, etc.
- Discovery Compound Screening Analytics Screening of an entire compound library directly against the drug target or in a more complex assay.
- Discovery Data Analysis Analysis that helps you make sense of your discovery data
- Discovery Data Integration The process of combining different complex data types together to make it easier to understand or analyze.
- Discovery Data Management A process that includes acquiring, validating, storing, protecting, and processing required data to ensure the accessibility, reliability, and timeliness of the data for its users.
- Discovery Data Science and Modeling A process that helps make sense of your discovery data
- Discovery Databases Databases specifically designed for drug discovery use.
- Discovery Drug Response Simulation Analytics Simulation of how a drug responds in different environments, from molecular to population studies.
- Discovery In Silico Drug Dynamics Develop In Silico model of a drug candidate with a biological system with applications such as Pro-drug Predictions, ADME-PK Due Diligence, Brain-Barrier Permeability Simulation, Drug Absorption Simulation, In Silico...
- Discovery In Silico Genomics/Transcriptomics Data Analysis A process that helps make sense of your Genomics/Transcriptomics data
- Discovery In Silico Proteome Analysis Used to understand the global protein environment, specifically drug-protein interactions.
- Discovery Machine Learning/AI Complex analytical approaches to find patterns and make predictions in drug discovery projects.
- Discovery Omics Analytics A process to analyze various omics data (genomics, transcriptomics, proteomics, metabolomics, etc.) This can include the integration of different omics data. Helps to better understand the molecular environment...
- Discovery Predictive Analytics Analytical approaches to predict how a drug target behaves in a given environment.
- Discovery Software Tools Software designed to serve the needs of discovery research groups.
- Discovery Statistical and Mathematical Modeling Use mathematical variables and equations to establish relationships between data.
- In Silico ADME-PK Consultation Consult with experts for ADME-PK data analysis or predictive modelling design in different in vivo or in vitro states.
- In Silico Drug-Drug Interactions Use computational tools to predict pharmaceutical, pharmacodynamic or pharmacokinetic drug-drug interactions to maximize drug regimen safety.
- In Silico Pro-drug Predictions Use computer simulation to assess pro-drug absorption and conversion to predict pharmacokinetic properties.
- In Silico Protein Microarray Analysis Use software to visualize and evaluate protein function and expression on a large scale.
- In Silico Protein Sequence Analysis Use software to predict protein structural and functional features and secondary structure components.
- RWE/HEOR Data Management A process that includes acquiring, validating, storing, protecting, and processing required data to ensure the accessibility, reliability, and timeliness of the data.
- RWE/HEOR Data Science and Modeling A process that helps make sense of your clinical data
- RWE/HEOR Machine Learning/AI Complex analytical approaches to find patterns and make predictions in RWE/HEOR projects
- Translational Bioinformatics Different analytical approaches that make, store, and analyze complex biological data.
- Translational Biomarker Discovery An approach to finding markers that change in response to a drug or that identify a group that responds favorably to a specific therapy. These can be omics, molecular, histologic, radiologic, etc.
- Translational Data Analysis Analysis that helps you make sense of your translational data
- Translational Data Curation Generally, human curation of acquired data to assess the quality and reliability of different data.
- Translational Data Harmonization and Integration Process to combine different data together for better understanding and analysis of the integrated data.
- Translational Data Knowledge Extraction Analytical approaches to extract data from different sources like publications, databases, etc.
- Translational Data Management A process that includes acquiring, validating, storing, protecting, and processing required data to ensure the accessibility, reliability, and timeliness of the data.
- Translational Data Science and Modeling A process that helps make sense of your translational data
- Translational In Silico Genomics/Transcriptomics Data Analysis A process that helps make sense of your omics data
- Translational Machine Learning/AI Complex analytical approaches to find patterns and make predictions in drug discovery projects.
- Translational Omics Analytics A process to analyze various omics data (genomics, transcriptomics, proteomics, metabolomics, etc.) This can include the integration of different omics data. Helps to better understand the molecular environment...
- Translational Software tools Software designed to serve the needs of translational research groups.
Discovery Chemistry
- Activity Prediction Identify possible chemical hits based on the known three-dimensional structure of a protein.
- Compound Docking Identify potential compound hits based on the 3D structure of a target protein.
- Discovery Computational Chemistry Model the interaction of a drug candidate with protein targets such as kinases, GPCRs, receptors, ion channels or enzymes.
- Hit to Lead (H2L) Evaluate, perform limited optimization and identify small molecule hits from high throughput screens.
- In Silico Metabolite Predictions Conduct in silico assessment of metabolite pharmacokinetic properties and potential exposure effects.
- Lead Optimization Perform chemical structural changes to improve preclinical drug candidate.
Show all 12 in Discovery Chemistry
- Library Design & Evaluation Use structural knowledge to design target-focused compound libraries for screening.
- Pharmacophore Modeling Use computer models to identify hits based on structural similarity to known active compounds.
- QSAR Analysis Develop quantitative structure–activity relationship models for drug design.
- Structure Activity Relationship (SAR) Analyze the relationship between the structure of a compound and its biological activity.
- Target-Focused Compound Libraries Find activity-based libraries directed towards a protein or cell signaling target.
- Virtual Screening Use software algorithms to virtually screen millions of potential compounds and peptides for binding.
DNA & RNA
- Integrated Genomics Package Process an entire Genomics Pipeline Project including: Sample Preparation, Target Enrichment, NGS Instrumentation, and Data Analysis from our Bundle of Suppliers
- Metagenomic Sequencing Sequence genetic material recovered directly from environmental samples
Drug Development
- Bioinformatics Consulting Consulting Services for the science of collecting and analyzing complex biological data
- Chemoinformatics Consulting The use of computer and informational techniques applied to a range of problems in the field of chemistry.
- Large Molecule Drug Development Consulting Develop large molecule drugs and complex biologics that have a therapeutic effect.
- Medicinal Chemistry Consulting Apply chemistry training to the process of synthesizing new pharmaceuticals.
- Pharmacogenetics Consulting Access genomic services required for clinical trials, such as genotyping, genetic variation testing and DNA isolation.
- Pharmacology Consulting Request consulting services related to pharmacology and the chemical properties, biological effects, and therapeutic uses of drugs.
Show all 10 in Drug Development
- Safety Pharmacology Consulting Consulting services that help with the detection of potential undesirable pharmacodynamic effects of chemical entities on physiological functions.
- Small Molecule Drug Development Consulting Request consulting services related to small molecule development.
- Target Validation Consulting Help to demonstrate that modification of target activity has potential therapeutic benefits.
- Toxicology Consulting Use models to assess acute and sub-acute toxicity as well as chronic and sub-chronic toxicity.
General Marketing
- Database Management Software Facilitate the collection, tracking and processing of biological facts, statistics and observations.
HEOR
- Clinical Outcome Assessments (Non-Patient Reported) Measure a patient's symptoms, mental state and level of disease condition-related impact on daily life.
- Clinical Outcomes Measures patient's symptoms, mental, or physical effects of a disease or condition on how the patient functions, recorded by practitioner, provider, or instrument (not by patient).
- Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
- Cost Benefit Analysis Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
- Cost Effectiveness Analysis Compare alternative treatments that lead to similar health outcomes.
- Decision Analytic Modeling Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.
Show all 13 in HEOR
- Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
- HEOR Adherence Studies Strategy or study that assess extent to which patients or subjects follow recommendations for prescribed intervention; may include compliance assessment, as well as reasons related to actual or potential non-adherence.
- Patient Reported Outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
- Patient Treatment Patterns Assessment of treatment processes and patterns within clinical practice.
- Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.
- Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.
- Therapy Switch Insight into the reasoning of patients switching treatments and the outcomes of the switch.
In Vitro ADME
- Drug Drug Interactions Determine whether a substance affects the activity of a drug when both are administered together.
- Metabolite Identification Identify drug metabolites that are formed after administration of drug to an animal model or patient.
- Metabolite Identification and Profiling Estimate drug candidate metabolites after administration of drug to an animal or human subject.
In Vitro Pharmacology
- Drug Target Assays Gain insight into the selectivity and mode-of-action of a compound's pharmacological targets.
- HuGEMM - Immuno-Oncology Model Evaluate human-specific therapeutics for checkpoint inhibitors, including anti-human PD-1, anti-human PDL-1, and anti-human CTLA-4 antibodies.
- Immuno-oncology Targets Develop drugs that take advantage of the immune system to target cancer cells.
- Protein Targets Protein Targets are of pharmaceutical interest for drug discovery purposes.
- Protein/Enzyme Targets For requesting Protein/Enzyme Targets
- Selectivity Profiling Determine the specificity of a ligand for its target by testing it against a large panel of related target proteins.
Show all 9 in In Vitro Pharmacology
- Target Characterization Characterize potential drug targets during the drug discovery process.
- Target Identification Identify the target(s) of a biologically active substance.
- Target Validation Demonstrate that modification of target activity has potential therapeutic benefits.
Market Access
- Formulary & Reimbursement Strategy Develop strategy and narrative to gain formulary access on insurance plans.
- Health Technology Assessment Submission (HTA Submission) Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern...
- Market Research & Business Intelligence Run market feasibility studies, establish customer needs, improve product performance and analyze competition.
- Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
- Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...
Medical/Commercial
- Health & Pharmacoeconomics Identify, measure and compare the cost-benefit ratio of products and services.
Model Development
- Custom Model Development Develop a custom disease model.
- Disease Model Database For sourcing disease models.
Old Category HEOR, RWE, Market Access
- Non-Interventional Studies Examine different aspects of drug usage, including efficacy and safety, under real-life conditions.
- Patient-Reported Outcome Studies Get self-reported information regarding the personal health status of an individual.
- RWE/RWD Enriched Studies Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.
Protein Sciences
- Antibody-Antigen Affinity Measurement Measure the binding kinetics of an antibody–antigen interaction.
- Mass Spectrometry-Based Proteomics Detect histone post-translational modifications (hPTMs), histone variants, and interactomes at chromatin regions.
- Protein Identification Uncover or confirm the identity of a protein.
- Protein Interaction Measure the interaction of a protein to other macromolecules or peptide ligands.
- Protein mapping Interrogate the entire sequence of a protein.
- Protein Post-translational Modification Analysis Measure glycosylation, phosphorylation, sulfation, ubiquitination, methylation and acetylation.
Show all 8 in Protein Sciences
- Protein Sequencing Determine the amino acid sequence of protein or peptide.
- Protein Services Consulting Expert advice to evaluate and analyze protein function and expression.
Real World Evidence & Data
- Claims Data & Database Analysis Analysis of care cost and quality.
- Claims Data - Medical Includes hospitalization,physician visits,emergency department visits. May or may not include laboratory information including resource utilization, costs or charges, as well as ICD-9 or 10 codes.
- Clinical Data Registry A study or collection of data regarding the health of patients and the care they receive over different time periods.
- Data Asset Validation Tools for validating that patient data and source has been accurately recorded.
- Exploratory Study Explore study design, outcomes, data-collection method, and selection of population for a topic that needs more research information.
- Meta-Analysis Use quantitative statistical approaches to pool results across multiple studies to improve power or resolve uncertainty; may be used in conjunction with a systematic review.
Show all 22 in Real World Evidence & Data
- Non-Comparative Study Assess an intervention using a single arm study design (without a control or comparator group).
- Patient Reported Outcomes (PRO) Databases Database or collection of data related to health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician or anyone else.
- Pragmatic Clinical Trial Randomized trial comparing two or more treatments in a real world setting. The trial possesses minimal exclusion criteria and closely follows the procedures of the clinical practice in order to mirror clinical care...
- Pregnancy Registries Database containing, through utilizing observational research methods, standardized data about women taking medication or vaccines while pregnant. Data may also collected on the newborn.
- Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
- Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
- Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
- Registries - Disease Database containing, through utilizing observational research methods, standardized data about patients who have the same disease.
- Registries - Patient Database containing, through utilizing observational research methods, standardized data about patients who have the same condition, disease, or exposure and is used to evaluate an outcome
- RWD - Electronic Medical Record (EMR) Digital version of a patient's medical or health chart containing demographic, clinical, medical, and other treatment information.
- RWD - Genomics Genomic data collected from a patients with different diseases, can be derived from a range of sources.
- RWD - Rare Diseases Data from patients with rare diseases, can include clinical treatment, diagnosis, among others.
- RWE/HEOR Data Analysis Analysis that helps you make sense of your RWE/HEOR data
- RWE/HEOR/Market Access Safety Surveillance Monitor safety of treatment and determine methods to identify adverse events early
- RWE/RWD Observational Research Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.
- Secondary Real World Evidence Analyze clinical trial data.
Regulatory Affairs
- Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
- Patient Risk Management Identify, contain, and manage risks related to patient safety.
- Period Benefit Risk Evaluation Report (PBRER) Preparation of safety reports to report adverse events that occurred during a specified time period. Evaluate if safety profile of treatment has changed since last report
- Periodic Safety Update Report (PSUR) Preparation of safety reports to report adverse events that occurred during a specified time period. Evaluate if safety profile of treatment has changed since last report
- Post Authorization Safety Study (PASS) Evaluate the safety, benefit-risk profile, and risk management of a treatment. These studies are specifically asked for by European Medicines Agency (EMA) and they can be mandatory or voluntary.
- Risk Benefit Assessment Determine ratio of treatment risk to the potential benefits.
Show all 8 in Regulatory Affairs
- Risk Evaluation & Mitigation Strategy (REMS) Evidence required by FDA to support the benefit of treatment outweighs the risks. Purpose of REMS is to prevent, monitor, and manage serious risk by informing, educating, and reinforcing actions to reduce frequency...
- Safety Signals Early indication that a new or unknown adverse event occurred that may be caused by treatment and investigation is needed to determine a causal relationship. Can be investigated through spontaneous reports, studies...
Safety Pharmacology
- CNS Behavioral Measure safety toxicology effects of CNS and behavioral drugs.
- Off Target Effects Assess toxicities by body weight, clinical chemistry, hematology, urinalysis and terminal necropsy and pathology.
- Safety Pharmacology Assess the impact of a therapeutic for human use on vital organ systems before first-in-man drug testing.
- Target Safety Assessment Understand the role of your drug target and assess risks in normal physiology.
Scientific Data Services
- Bayesian Statistics Extract information from data sets that are subject to error or noise to see unobserved possibilities.
- Bioinformatics Bioinformatics is a powerful method of storing, retrieving and analyzing biological data.
- Cancer Systems Biology Convert complex molecular data obtained from high-throughput technologies to deducible information.
- Cloud Computing Request on-demand computer resources specifically relating to large data storage and computing power.
- Data and Text Mining Derive structured data from free text in order to become accessible for data-mining algorithms.
- Data Curation Organize and integrate data collected from various sources to ease data discovery and retrieval.
Show all 30 in Scientific Data Services
- Data Infrastructure Design and deploy an information management solution suited to users' specific needs.
- Database Integration Convert bioinformatics results from multiple data sources (DSs) into a single operational format.
- Discovery Computational Systems Biology Model the interaction of biological system with drug candidates.
- Epigenomics Data Analysis Quantify and analyze DNA methylation and/or DNA binding protein data sets.
- Large Language Models Use of Large Language models in target discovery, clinical trial design and development, analysis of clinical trial data and regulatory submissions. Services are tailored to the problem, specific context of biopharma.
- LIM/eLab Notebook Services LIM/eLab Notebook Services
- Machine Learning/ AI Predict and model an outcome (e.g. disease progression) based on input variables (i.e. features.)
- Marker Analyses Identify associations between genetic markers and traits of interest to determine markers responsible for human diseases.
- Metabolomics Data Analysis Use metabolites to identify any potential biomarkers or novel therapeutic targets that may play a role in the mechanisms responsible for the progression of a disease.
- Metagenomics Data Analysis Deconvolute the genetic content of genomes contained in environmental samples by utilizing whole genome sequencing techniques to provide insight into microbial communities and host phenotypes.
- Microbiome Data Analysis Determine the population composition of a microbial community and analyze its contribution to human or animal health.
- Molecular Dynamics Software Run simulations that determine time-dependent behaviors of molecular systems.
- Mutation Data Profiling Guide treatment decisions in cancer based on the identification of genomic mutations .
- Omics Informatics Consulting Services for the analysis of large-scale molecular data sets.
- Ontology Mapping Assign given ontologies to source data.
- Pharmaco-genomics Genetic polymorphism contribution to inter-individual variability in drugs' responses and/or adverse events.
- Scientific Data Visualization Exploration and reporting of data by means of graphs and plots.
- Scientific Pipeline Implementation Design, develop and deploy data analyses workflows.
- Semantic Tech & Triplestores Store and retrieve semantic facts.
- Small RNA Gene Expression Quantify and analyze miRNA, piRNA, siRNA as well as other small nuclear RNAs from small-RNA-seq raw input data sets.
- Software Tools Software tool for statistical analysis, data mining, genome annotation or NGS data analysis.
- Systems Biomedicine Analyze complex interactions in biological systems with interdisciplinary scientific teams.
- Systems Network Analysis Analyze and visualize molecular pathways including gene regulatory, protein-protein and drug-target networks.
- Systems Pharmacology Understand how drugs interact with different molecular and cellular systems within biological models.
Other services
- Observational Research Gain valuable insights into the association between a drug treatment and its outcomes such as long-term effectiveness and safety.
- Website
- www.excelra.com
Where it operates
Sites by country, with the cities in each.
-
India 2 sites
-
Belgium 1 site
-
United States 1 site
Work with Excelra on Scientist.com
For prices, more details, or to contact Excelra, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.